BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 10979894)

  • 1. Epstein-Barr virus gene expression in the peripheral blood of transplant recipients with persistent circulating virus loads.
    Qu L; Green M; Webber S; Reyes J; Ellis D; Rowe D
    J Infect Dis; 2000 Oct; 182(4):1013-21. PubMed ID: 10979894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus gene expression and latent membrane protein 1 gene polymorphism in pediatric liver transplant recipients.
    Kasztelewicz B; Jankowska I; Pawłowska J; Teisseyre J; Dzierżanowska-Fangrat K
    J Med Virol; 2011 Dec; 83(12):2182-90. PubMed ID: 22012727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-barr virus gene expression, human leukocyte antigen alleles and chronic high viral loads in pediatric renal transplant patients.
    Moran J; Carr M; Waters A; Boyle S; Riordan M; Connell J; Awan A; Hall W; Hassan J
    Transplantation; 2011 Aug; 92(3):328-33. PubMed ID: 21685826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic and virologic analyses in pediatric liver transplant recipients with chronic high Epstein-Barr virus loads.
    Gotoh K; Ito Y; Ohta R; Iwata S; Nishiyama Y; Nakamura T; Kaneko K; Kiuchi T; Ando H; Kimura H
    J Infect Dis; 2010 Aug; 202(3):461-9. PubMed ID: 20560768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
    Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
    J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
    Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
    AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneous, restricted patterns of Epstein-Barr virus (EBV) latent gene expression in patients with chronic active EBV infection.
    Yoshioka M; Ishiguro N; Ishiko H; Ma X; Kikuta H; Kobayashi K
    J Gen Virol; 2001 Oct; 82(Pt 10):2385-2392. PubMed ID: 11562532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus (EBV) early-antigen serologic testing in conjunction with peripheral blood EBV DNA load as a marker for risk of posttransplantation lymphoproliferative disease.
    Carpentier L; Tapiero B; Alvarez F; Viau C; Alfieri C
    J Infect Dis; 2003 Dec; 188(12):1853-64. PubMed ID: 14673764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of heterogeneous Epstein-Barr virus gene expression patterns within individual post-transplantation lymphoproliferative disorders.
    Oudejans JJ; Jiwa M; van den Brule AJ; Grässer FA; Horstman A; Vos W; Kluin PM; van der Valk P; Walboomers JM; Meijer CJ
    Am J Pathol; 1995 Oct; 147(4):923-33. PubMed ID: 7573368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol].
    Merlino C; Giacchino F; Bergallo M; Bonello F; Bollero C; Segoloni GP; Cavallo R
    G Ital Nefrol; 2003; 20(2):170-5. PubMed ID: 12746803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients.
    Lee TC; Savoldo B; Barshes NR; Rooney CM; Heslop HE; Gee AP; Caldwell Y; Scott JD; Goss JA
    Clin Transplant; 2006; 20(3):389-93. PubMed ID: 16824159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of ZEBRA protein of Epstein-Barr virus in Hungarian patients with Hodgkin lymphoma: latent or lytic cycle?].
    Beck Z; Illés A; Keresztes K; Bessenyei B; Szöllosi Z; Kis A; Oláh E
    Orv Hetil; 2006 Aug; 147(33):1539-44. PubMed ID: 17037676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
    J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of Epstein-Barr virus genome copy number and BZLF1 expression in blood lymphocytes of transplant recipients at risk for lymphoproliferative disease.
    Vajro P; Lucariello S; Migliaro F; Sokal E; Gridelli B; Vegnente A; Iorio R; Smets F; Quinto I; Scala G
    J Infect Dis; 2000 Jun; 181(6):2050-4. PubMed ID: 10837191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of Epstein-Barr virus load in Argentinean transplant recipients using real-time PCR.
    Yancoski J; Danielian S; Ibañez J; Turconi A; Cuarterolo M; Zelazko M; Niesters Hubert GM
    J Clin Virol; 2004 Sep; 31(1):58-65. PubMed ID: 15288615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus infection is not associated with fibroadenomas of the breast in immunosuppressed patients after organ transplantation.
    Lau SK; Chen YY; Berry GJ; Yousem SA; Weiss LM
    Mod Pathol; 2003 Dec; 16(12):1242-7. PubMed ID: 14681325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of Epstein-Barr virus (EBV)-related gene expression in patients with chronic active EBV infection.
    Iwata S; Wada K; Tobita S; Gotoh K; Ito Y; Demachi-Okamura A; Shimizu N; Nishiyama Y; Kimura H
    J Gen Virol; 2010 Jan; 91(Pt 1):42-50. PubMed ID: 19793909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection.
    Bauer CC; Aberle SW; Popow-Kraupp T; Kapitan M; Hofmann H; Puchhammer-Stöckl E
    J Med Virol; 2005 Jan; 75(1):54-8. PubMed ID: 15543583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of Epstein-Barr virus genes in EBV-associated gastric carcinoma].
    Wang Y; Luo B; Zhao P; Huang BH
    Ai Zheng; 2004 Jul; 23(7):782-7. PubMed ID: 15248912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of a low cellular immune response to aid in identification of pediatric liver transplant recipients at high-risk for EBV infection.
    Lee TC; Goss JA; Rooney CM; Heslop HE; Barshes NR; Caldwell YM; Gee AP; Scott JD; Savoldo B
    Clin Transplant; 2006; 20(6):689-94. PubMed ID: 17100717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.